Is ELV stock a Buy, Sell, or Hold?

Based on our analysis, ELV is currently a WAIT with low confidence. 📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of ELV stock?

Our analysis estimates the fair value range for ELV to be between $390.02 and $407.40. The current price is $418.72.

What is the analyst price target for ELV?

The average Wall Street analyst price target for ELV is $450.05. This implies a potential upside of 7.5% from current levels.

Elevance Health (ELV) Stock: Buy, Sell, or Hold?

ELV - Elevance Health, Inc.

HOSPITAL & MEDICAL SERVICE PLANS

$418.72

2.18 (0.52%) ▲

5d: +0.95%

30d: +4.91%

90d: +4.9%

WAIT

LOW Confidence

Protect Your ELV Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Oct 20, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 8, 2026 at $403.53 · last confirmed Sep 11, 2026

Strength: 7.5/10

Get Alerted When ELV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 9.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$506.68

Based on 6.5% avg growth

INTRINSIC VALUE TODAY

$314.61

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ELV is currently trading at $418.72, which is considered extended relative to its 30-day fair value range of $390.02 to $407.40. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.1) compared to its historical average (12.5). At these levels, the market is pricing in 4.2% annual earnings growth.

Technical Outlook: Technically, ELV is in a uptrend. The price is approaching resistance at $426.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ELV scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $390.02 - $407.40

Company Quality Score 45/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 27.1%

Protect Your Profits

Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BEARISH: Weak technical setup (38/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($450.05)
BULLISH: Expecting earnings turnaround to 4.2% growth with 1.4% revenue growth
WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $390.02 - $407.40

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $390.80

Resistance Level $426.39

Current Trend Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 14.14

Wall Street Target $450.05 (+7.5%)

Revenue Growth (YoY) 1.4%

Earnings Growth (YoY) -13.1%

Profit Margin 2.5%

Valuation Premium vs History +4.2% premium

PE vs Historical 14.1 vs 12.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +4.2% (market-implied from PE analysis)

1-Year Target $436.31 (+4%)

2-Year Target $454.63 (+9%)

3-Year Target $473.73 (+13%)

3-Yr Target (if PE normalizes) (PE: 14→13) PE COMPRESSION $418.68 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 9.0%) $773.39 (+85%)

Base: (SPY PE: 14.1, Growth: 9.0%) $542.30 (+30%)

Bear: (PE: 12.0, Growth: 9.0%) $460.96 (+10%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (14x PE) as earnings recover.

Trailing PE: 17.55 | Current EPS (TTM): $23.74

Bull Case $571.40 (+37%)

Analyst growth 24.7%, PE expands to 19.3

Base Case $519.46 (+24%)

Market implied 24.7%, PE stable at 17.6

Bear Case $283.25 (-32%)

Severe decline -20.0%, PE contracts to 14.9

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 11, 2026 9:42 PM ET
Data refreshes hourly during market hours. Next update: 10:42 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ELV showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Ro Khanna SELL 2026-03-30

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ELV.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
CVS CVS Health Corp	STRONG BUY 28 analysts	$116	50 HOLD
UNH UnitedHealth Group Incor…	STRONG BUY 27 analysts	$475	49 HOLD
CI Cigna Corp	STRONG BUY 25 analysts	$341	51 HOLD
HUM Humana Inc	HOLD 26 analysts	$419	49 HOLD
CNC Centene Corp	BUY 19 analysts	$72	47 HOLD

CVS CVS Health Corp

50 HOLD

UNH UnitedHealth Grou…

Advanced ELV Option Strategies

Professional options setups generated by AI based on today's ELV price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ELV

ELV Technical Chart ELV Price Prediction ELV Earnings Date ELV Investment Advisor ELV Fair Price Analyzer ELV Options Advisor ELV Options Chain ELV Options Analysis ELV Competitors

Compare ELV with Peers

ELV vs MOH
Which one to buy?

ELV vs HUM
Which one to buy?

ELV vs CNC
Which one to buy?

ELV vs CI
Which one to buy?

ELV vs HCA
Which one to buy?

ELV vs CNC
Winner: ELV

HUM vs ELV
Winner: ELV

ELV vs PGNY

MOH vs ELV

ELV vs ALHC
Winner: ELV

ELV vs OSCR
Winner: ELV

Create New Comparison View All Competitors

Tradestie